Polaramine and Psychotic disorder - a phase IV clinical study of FDA data

Summary:

Psychotic disorder is reported only by a few people who take Polaramine.

The phase IV clinical study analyzes which people take Polaramine and have Psychotic disorder. It is created by eHealthMe based on reports of 8,515 people who have side effects while taking Polaramine from the FDA, and is updated regularly.

With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.



On Jun, 30, 2022

8,515 people reported to have side effects when taking Polaramine.
Among them, 3 people (0.04%) have Psychotic disorder.


What is Polaramine?

Polaramine has active ingredients of dexchlorpheniramine maleate. It is often used in allergic rhinitis. eHealthMe is studying from 8,566 Polaramine users for its effectiveness, alternative drugs and more.

What is Psychotic disorder?

Psychotic disorder is found to be associated with 1,747 drugs and 1,395 conditions by eHealthMe.

Number of Polaramine and Psychotic disorder reports submitted per year:

Could Polaramine cause Psychotic disorder?

Gender of people who have Psychotic disorder when taking Polaramine *:

  • female: 0.0 %
  • male: 100 %

Age of people who have Psychotic disorder when taking Polaramine *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

Common drugs people take besides Polaramine *:

  1. Taxol: 1 person, 33.33%
  2. Solu-Medrol: 1 person, 33.33%
  3. Sandimmune: 1 person, 33.33%
  4. Ranitidine: 1 person, 33.33%
  5. Ondansetron: 1 person, 33.33%
  6. Noxafil: 1 person, 33.33%
  7. Haldol: 1 person, 33.33%
  8. Fluorouracil: 1 person, 33.33%
  9. Dexamethasone: 1 person, 33.33%
  10. Cordarone: 1 person, 33.33%

Common side effects people have besides Psychotic disorder *:

  1. Agitation (state of anxiety or nervous excitement): 2 people, 66.67%
  2. Urinary Incontinence (inability to control the flow of urine and involuntary urination): 1 person, 33.33%
  3. Shock (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin): 1 person, 33.33%
  4. Blood Glucose Increased: 1 person, 33.33%
  5. Bradyphrenia (neurological term referring to the slowness of thought common to many disorders of the brain): 1 person, 33.33%
  6. Confusional State: 1 person, 33.33%
  7. Delirium (wild excitement): 1 person, 33.33%
  8. Delusion (a false belief or opinion): 1 person, 33.33%
  9. Feeling Abnormal: 1 person, 33.33%
  10. Hallucinations (sensations that appear real but are created by your mind): 1 person, 33.33%

Common conditions people have *:

  1. Sarcoidosis (an inflammatory disease that affects multiple organs in the body, but mostly the lungs and lymph glands): 1 person, 33.33%
  2. Parkinson's Disease: 1 person, 33.33%
  3. Bone Marrow Failure: 1 person, 33.33%
  4. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 33.33%

* Approximation only. Some reports may have incomplete information.

Do you take Polaramine and have Psychotic disorder?

Check whether Psychotic disorder is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related publications that referenced our studies

Related studies

Alternative drugs to, pros and cons of Polaramine:

Psychotic disorder treatments and more:

COVID vaccines that are related to Psychotic disorder:

How severe was Psychotic disorder and when was it recovered:

Expand to all the drugs that have ingredients of dexchlorpheniramine maleate:

Common drugs associated with Psychotic disorder:

All the drugs that are associated with Psychotic disorder:

Common conditions associated with Psychotic disorder:

All the conditions that are associated with Psychotic disorder:

How the study uses the data?

The study uses data from the FDA. It is based on dexchlorpheniramine maleate (the active ingredients of Polaramine) and Polaramine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: